Siga Technologies (SIGA) EPS (Basic) Growth (1y) (2011 - 2025)
Powered by 
Analysis
Siga Technologies (SIGA) EPS (Basic) Growth (1y) (2011 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.17 Bn | 622.42 Bn | 17.26 Bn | -0.10% |
| 2 | AbbVie | 446.97 Bn | 440.40 Bn | 12.70 Bn | 284.05% |
| 3 | Merck | 359.56 Bn | 352.42 Bn | 12.21 Bn | -130.68% |
| 4 | Novartis Ag | 269.46 Bn | 261.77 Bn | 11.24 Bn | -15.94% |
| 5 | Pfizer | 156.92 Bn | 145.22 Bn | 10.94 Bn | -108.11% |
| 6 | Sanofi | 52.38 Bn | 45.00 Bn | 10.79 Bn | -91.06% |
| 7 | Revolution Medicines | 43.58 Bn | 43.58 Bn | - | - |
| 8 | Incyte | 25.22 Bn | 20.68 Bn | 1.57 Bn | 39.99% |
| 9 | United Therapeutics | 21.29 Bn | 18.63 Bn | 683.80 Mn | 13.91% |
| 10 | Siga Technologies | 215.53 Mn | 60.56 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -572.10% |
| Jun 30, 2025 | 1,864.41% |
| Mar 31, 2025 | -103.59% |
| Dec 31, 2024 | -36.57% |
| Sep 30, 2024 | 440.55% |
| Jun 30, 2024 | 162.47% |
| Mar 31, 2024 | 1,237.31% |
| Dec 31, 2023 | 9,196.22% |
| Sep 30, 2023 | -101.22% |
| Jun 30, 2023 | -247.91% |
| Mar 31, 2023 | -157.24% |
| Dec 31, 2022 | -101.14% |
| Sep 30, 2022 | 1,187.65% |
| Jun 30, 2022 | 900.67% |
| Mar 31, 2022 | 78.09% |
| Dec 31, 2021 | 283.01% |
| Sep 30, 2021 | -113.43% |
| Jun 30, 2021 | -101.31% |
| Mar 31, 2021 | 79.41% |
| Dec 31, 2020 | 527.72% |